Dipeptidylpeptidase-4 inhibitors: risk of acute pancreatitis

There have been reports of acute pancreatitis associated with drugs in the dipeptidylpeptidase-4 (DPP-4) inhibitor class of antidiabetic agents (‘gliptins’).